“…These studies have been carried out in Austria, Germany, Italy, France, Hungary, the Netherlands, Romania, and Serbia, reporting an USUV antibody prevalence between 0.02% and 3% among healthy blood donors [ 32 , 62 , 69 , 71 , 72 , 75 , 77 , 78 , 79 , 80 , 81 , 82 ]. Higher prevalence (6/7%) was found in more exposed populations, such as forestry workers [ 60 , 78 , 83 ]. Several of these studies show that USUV circulates more actively in humans than WNV in Europe, and prevalence studies of USUV infection in mosquito vectors in Europe also highlight a higher level of exposure to USUV than to WNV [ 18 , 84 , 85 ].…”